Skip to main content
Erschienen in: Annals of Surgical Oncology 5/2016

15.08.2016 | Head and Neck Oncology

Short- and Long-Term Outcomes of Larynx-Preserving Surgery for Cervical Esophageal Cancer: Analysis of 100 Consecutive Cases

verfasst von: Tomoki Makino, MD, PhD, Makoto Yamasaki, MD, PhD, Yasuhiro Miyazaki, MD, PhD, Tsuyoshi Takahashi, MD, PhD, Yukinori Kurokawa, MD, PhD, Kiyokazu Nakajima, MD, PhD, Shuji Takiguchi, MD, PhD, Masaki Mori, MD, PhD, Yuichiro Doki, MD, PhD

Erschienen in: Annals of Surgical Oncology | Sonderheft 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Surgical interventions for cervical esophageal cancer (CEC), particularly larynx-preserving procedures, have not yet been standardized in terms of short- and long-term outcome.

Methods

We retrospectively analyzed 100 consecutive surgeries for CEC in our department. We compared clinicopathological parameters and long-term outcomes between larynx-preserving esophagectomies (LP group) and nonpreserving procedures (NP group). We also evaluated preoperative predictive parameters for larynx-preservation.

Results

Compared with the NP group, the LP group had significantly lower cT (P < 0.001) and cStage (P = 0.001) and shorter tumor length (P = 0.0108). Multivariate logistic regression analysis identified early cT stage, early cStage, and response to preoperative treatment as significant predictive parameters of larynx preservation. Larynx-preserving procedures could be performed for 90.5 % of T1–2 tumors regardless of preoperative treatment response. In contrast in T3–4 tumors, most nonresponders (92.3 %) were ineligible for larynx-preservation (P = 0.0012), whereas 54.3 % of responders could achieve larynx preservation. The average shortening of upward extension in T3–4 tumors after preoperative treatment was 20.0 mm in the LP group vs. 10.2 mm in the NP group (P = 0.051). The two groups were similar in terms of overall morbidity (including pneumonia), mortality, and postoperative hospital days. Importantly, larynx preservation for CEC neither worsened patient prognosis nor increased locoregional recurrence compared to the NP group.

Conclusions

Larynx-preserving esophagectomy for CEC is feasible and oncologically acceptable. The cT, cStage, and clinical response to preoperative treatment are important preoperative predictors of a patient’s suitability for larynx-preservation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Laterza E, Mosciaro O, Urso US, Inaspettato G and Cordiano C. Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy. Hepato Gastroenterology. 1994;41:278–82.PubMed Laterza E, Mosciaro O, Urso US, Inaspettato G and Cordiano C. Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy. Hepato Gastroenterology. 1994;41:278–82.PubMed
2.
Zurück zum Zitat Lee DJ, Harris A, Gillette A, Munoz L and Kashima H. Carcinoma of the cervical esophagus: diagnosis, management, and results. South. Med J. 1984;77:1365–7.CrossRefPubMed Lee DJ, Harris A, Gillette A, Munoz L and Kashima H. Carcinoma of the cervical esophagus: diagnosis, management, and results. South. Med J. 1984;77:1365–7.CrossRefPubMed
3.
Zurück zum Zitat NCCN. National comprehensive cancer network clinical practice guidelines in oncology. National Comprehensive Cancer Network, Fort Washington. 2011. NCCN. National comprehensive cancer network clinical practice guidelines in oncology. National Comprehensive Cancer Network, Fort Washington. 2011.
4.
Zurück zum Zitat Tong DK, Law S, Kwong DL, Wei WI, Ng RW, Wong KH. Current management of cervical esophageal cancer. World J Surg. 2011;35:600–7.CrossRefPubMed Tong DK, Law S, Kwong DL, Wei WI, Ng RW, Wong KH. Current management of cervical esophageal cancer. World J Surg. 2011;35:600–7.CrossRefPubMed
5.
Zurück zum Zitat Wang S, Liao Z, Chen Y, Chang JY, Jeter M, Guerrero T, et al. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience. J Thorac Oncol. 2006;1:252–9.CrossRefPubMed Wang S, Liao Z, Chen Y, Chang JY, Jeter M, Guerrero T, et al. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience. J Thorac Oncol. 2006;1:252–9.CrossRefPubMed
6.
Zurück zum Zitat Uno T, Isobe K, Kawakami H, Ueno N, Shimada H, Matsubara H, et al. Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus. Dis Esophagus. 2007;20:12–8.CrossRefPubMed Uno T, Isobe K, Kawakami H, Ueno N, Shimada H, Matsubara H, et al. Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus. Dis Esophagus. 2007;20:12–8.CrossRefPubMed
7.
Zurück zum Zitat Bidoli P, Bajetta E, Stani SC, De CD, Santoro A, Valente M, et al. Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus. Cancer. 2002;94:352–61.CrossRefPubMed Bidoli P, Bajetta E, Stani SC, De CD, Santoro A, Valente M, et al. Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus. Cancer. 2002;94:352–61.CrossRefPubMed
8.
Zurück zum Zitat Stuschke M, Stahl M, Wilke H, Walz MK, Oldenburg AR, Stuben G, et al. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus. Oncology. 1999;57:99–105.CrossRefPubMed Stuschke M, Stahl M, Wilke H, Walz MK, Oldenburg AR, Stuben G, et al. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus. Oncology. 1999;57:99–105.CrossRefPubMed
9.
Zurück zum Zitat Wang HW, Chu PY, Kuo KT, Yang CH, Chang SY, Hsu WH, et al. A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction. J Surg Oncol. 2006;93:468–76.CrossRefPubMed Wang HW, Chu PY, Kuo KT, Yang CH, Chang SY, Hsu WH, et al. A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction. J Surg Oncol. 2006;93:468–76.CrossRefPubMed
10.
Zurück zum Zitat Ott K, Lordick F, Molls M, Bartels H, Biemer E and Siewert JR. Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg. 2009;96:258–66.CrossRefPubMed Ott K, Lordick F, Molls M, Bartels H, Biemer E and Siewert JR. Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg. 2009;96:258–66.CrossRefPubMed
11.
Zurück zum Zitat Kadota H, Sakuraba M, Kimata Y, Hayashi R, Ebihara S, Kato H. Larynx-preserving esophagectomy and jejunal transfer for cervical esophageal carcinoma. Laryngoscope. 2009;119:1274–80.CrossRefPubMed Kadota H, Sakuraba M, Kimata Y, Hayashi R, Ebihara S, Kato H. Larynx-preserving esophagectomy and jejunal transfer for cervical esophageal carcinoma. Laryngoscope. 2009;119:1274–80.CrossRefPubMed
12.
Zurück zum Zitat Sobin L GM, Wittekind C. TNM Classification of malignant tumours, 7th edn. New York: Wiley; 2009. Sobin L GM, Wittekind C. TNM Classification of malignant tumours, 7th edn. New York: Wiley; 2009.
13.
Zurück zum Zitat Makino T, Miyata H, Yamasaki M, Fujiwara Y, Takiguchi S, Nakajima K, et al. Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma. Surgery. 2010;148:908–18.CrossRefPubMed Makino T, Miyata H, Yamasaki M, Fujiwara Y, Takiguchi S, Nakajima K, et al. Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma. Surgery. 2010;148:908–18.CrossRefPubMed
14.
Zurück zum Zitat Makino T, Doki Y, Miyata H, Yasuda T, Yamasaki M, Fujiwara Y, et al. Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma. Surgery. 2008;144:793–802.CrossRefPubMed Makino T, Doki Y, Miyata H, Yasuda T, Yamasaki M, Fujiwara Y, et al. Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma. Surgery. 2008;144:793–802.CrossRefPubMed
15.
Zurück zum Zitat Miyata H, Yamasaki M, Takahashi T, Murakami K, Kurokawa Y, Nakajima K, et al. Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer. Br J Surg. 2013;100:1490–7.CrossRefPubMed Miyata H, Yamasaki M, Takahashi T, Murakami K, Kurokawa Y, Nakajima K, et al. Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer. Br J Surg. 2013;100:1490–7.CrossRefPubMed
16.
Zurück zum Zitat Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Konishi K, et al. Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer. Ann Surg. 2011;253:279–84.CrossRefPubMed Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Konishi K, et al. Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer. Ann Surg. 2011;253:279–84.CrossRefPubMed
17.
Zurück zum Zitat Yamasaki M, Miyata H, Tanaka K, Shiraishi O, Motoori M, Peng YF, et al. Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus. Oncology. 2011;80:307–13.CrossRefPubMed Yamasaki M, Miyata H, Tanaka K, Shiraishi O, Motoori M, Peng YF, et al. Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus. Oncology. 2011;80:307–13.CrossRefPubMed
18.
Zurück zum Zitat Miyata H, Yamasaki M, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, et al. Larynx-preserving limited resection and free jejunal graft for carcinoma of the cervical esophagus. World J Surg. 2013;37:551–7.CrossRefPubMed Miyata H, Yamasaki M, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, et al. Larynx-preserving limited resection and free jejunal graft for carcinoma of the cervical esophagus. World J Surg. 2013;37:551–7.CrossRefPubMed
19.
Zurück zum Zitat Sun F, Li X, Lei D, Jin T, Liu D, Zhao H, et al. Surgical management of cervical esophageal carcinoma with larynx preservation and reconstruction. Int J Clin Exp Med. 2014;7:2771–8.PubMedPubMedCentral Sun F, Li X, Lei D, Jin T, Liu D, Zhao H, et al. Surgical management of cervical esophageal carcinoma with larynx preservation and reconstruction. Int J Clin Exp Med. 2014;7:2771–8.PubMedPubMedCentral
20.
Zurück zum Zitat Shiozaki H, Tsujinaka T, Inoue M, Yano M, Doki Y, Miyaguchi M, et al. Larynx preservation in surgical treatment of cervical esophageal cancer: combined procedure of laryngeal suspension and cricopharyngeal myotomy. Dis Esophagus. 2000;13:213–8.CrossRefPubMed Shiozaki H, Tsujinaka T, Inoue M, Yano M, Doki Y, Miyaguchi M, et al. Larynx preservation in surgical treatment of cervical esophageal cancer: combined procedure of laryngeal suspension and cricopharyngeal myotomy. Dis Esophagus. 2000;13:213–8.CrossRefPubMed
21.
Zurück zum Zitat Yasuda T, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, et al. Evaluation of dysphagia and diminished airway protection after three-field esophagectomy and a remedy. World J Surg. 2013;37:416–23.CrossRefPubMed Yasuda T, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, et al. Evaluation of dysphagia and diminished airway protection after three-field esophagectomy and a remedy. World J Surg. 2013;37:416–23.CrossRefPubMed
22.
Zurück zum Zitat Carlson GW, Schusterman MA and Guillamondegui OM. Total reconstruction of the hypopharynx and cervical esophagus: a 20-year experience. Ann Plast Surg. 1992;29:408–12.CrossRefPubMed Carlson GW, Schusterman MA and Guillamondegui OM. Total reconstruction of the hypopharynx and cervical esophagus: a 20-year experience. Ann Plast Surg. 1992;29:408–12.CrossRefPubMed
23.
Zurück zum Zitat Kakegawa T, Yamana H and Ando N. Analysis of surgical treatment for carcinoma situated in the cervical esophagus. Surgery. 1985;97:150–7.PubMed Kakegawa T, Yamana H and Ando N. Analysis of surgical treatment for carcinoma situated in the cervical esophagus. Surgery. 1985;97:150–7.PubMed
24.
Zurück zum Zitat Mansour KA, Picone AL and Coleman JJ, 3rd. Surgery for high cervical esophageal carcinoma: experience with 11 patients. Ann Thorac Surg. 1990;49:597–601 (discussion 601–2). Mansour KA, Picone AL and Coleman JJ, 3rd. Surgery for high cervical esophageal carcinoma: experience with 11 patients. Ann Thorac Surg. 1990;49:597–601 (discussion 6012).
25.
Zurück zum Zitat Kelley DJ, Wolf R, Shaha AR, Spiro RH, Bains MS, Kraus DH, et al. Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus. Am J Surg. 1995;170:427–31.CrossRefPubMed Kelley DJ, Wolf R, Shaha AR, Spiro RH, Bains MS, Kraus DH, et al. Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus. Am J Surg. 1995;170:427–31.CrossRefPubMed
26.
Zurück zum Zitat Triboulet JP, Mariette C, Chevalier D and Amrouni H. Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases. Arch Surg. 2001;136:1164–70.CrossRefPubMed Triboulet JP, Mariette C, Chevalier D and Amrouni H. Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases. Arch Surg. 2001;136:1164–70.CrossRefPubMed
27.
Zurück zum Zitat Shirakawa Y, Naomoto Y, Noma K, Ono R, Nobuhisa T, Kobayashi M, et al. Free jejunal graft for hypopharyngeal and esophageal reconstruction. Langenbeck’s Arch Surg. 2004;389:387–90.CrossRef Shirakawa Y, Naomoto Y, Noma K, Ono R, Nobuhisa T, Kobayashi M, et al. Free jejunal graft for hypopharyngeal and esophageal reconstruction. Langenbeck’s Arch Surg. 2004;389:387–90.CrossRef
28.
Zurück zum Zitat Bergquist H, Ejnell H, Fogdestam I, Mark H, Mercke C, Lundell L, et al. Functional long-term outcome of a free jejunal transplant reconstruction following chemoradiotherapy and radical resection for hypopharyngeal and proximal oesophageal carcinoma. Digest Surg. 2004;21:426–31 (discussion 432–3). Bergquist H, Ejnell H, Fogdestam I, Mark H, Mercke C, Lundell L, et al. Functional long-term outcome of a free jejunal transplant reconstruction following chemoradiotherapy and radical resection for hypopharyngeal and proximal oesophageal carcinoma. Digest Surg. 2004;21:426–31 (discussion 4323).
29.
Zurück zum Zitat Daiko H, Hayashi R, Saikawa M, Sakuraba M, Yamazaki M, Miyazaki M, et al. Surgical management of carcinoma of the cervical esophagus. J Surg Oncol. 2007;96:166–72.CrossRefPubMed Daiko H, Hayashi R, Saikawa M, Sakuraba M, Yamazaki M, Miyazaki M, et al. Surgical management of carcinoma of the cervical esophagus. J Surg Oncol. 2007;96:166–72.CrossRefPubMed
30.
Zurück zum Zitat Ferahkose Z, Bedirli A, Kerem M, Azili C, Sozuer EM and Akin M. Comparison of free jejunal graft with gastric pull-up reconstruction after resection of hypopharyngeal and cervical esophageal carcinoma. Dis Esophagus. 2008;21:340–5.CrossRefPubMed Ferahkose Z, Bedirli A, Kerem M, Azili C, Sozuer EM and Akin M. Comparison of free jejunal graft with gastric pull-up reconstruction after resection of hypopharyngeal and cervical esophageal carcinoma. Dis Esophagus. 2008;21:340–5.CrossRefPubMed
31.
Zurück zum Zitat Grass GD, Cooper SL, Armeson K, Garrett-Mayer E and Sharma A. Cervical esophageal cancer: a population-based study. Head Neck. 2015;37:808–14.CrossRefPubMed Grass GD, Cooper SL, Armeson K, Garrett-Mayer E and Sharma A. Cervical esophageal cancer: a population-based study. Head Neck. 2015;37:808–14.CrossRefPubMed
32.
Zurück zum Zitat Huang SH, Lockwood G, Brierley J, Cummings B, Kim J, Wong R, et al. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Rad Oncol Biol Phys. 2008;71:735–40.CrossRef Huang SH, Lockwood G, Brierley J, Cummings B, Kim J, Wong R, et al. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Rad Oncol Biol Phys. 2008;71:735–40.CrossRef
33.
Zurück zum Zitat Yamada K, Murakami M, Okamoto Y, Okuno Y, Nakajima T, Kusumi F, et al. Treatment results of radiotherapy for carcinoma of the cervical esophagus. Acta Oncol. 2006;45:1120–5.CrossRefPubMed Yamada K, Murakami M, Okamoto Y, Okuno Y, Nakajima T, Kusumi F, et al. Treatment results of radiotherapy for carcinoma of the cervical esophagus. Acta Oncol. 2006;45:1120–5.CrossRefPubMed
Metadaten
Titel
Short- and Long-Term Outcomes of Larynx-Preserving Surgery for Cervical Esophageal Cancer: Analysis of 100 Consecutive Cases
verfasst von
Tomoki Makino, MD, PhD
Makoto Yamasaki, MD, PhD
Yasuhiro Miyazaki, MD, PhD
Tsuyoshi Takahashi, MD, PhD
Yukinori Kurokawa, MD, PhD
Kiyokazu Nakajima, MD, PhD
Shuji Takiguchi, MD, PhD
Masaki Mori, MD, PhD
Yuichiro Doki, MD, PhD
Publikationsdatum
15.08.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe Sonderheft 5/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5511-x

Weitere Artikel der Sonderheft 5/2016

Annals of Surgical Oncology 5/2016 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.